Sole-source purchase of bebtelovimab
Ended Purchase Order Awarded Last action
- Contract number
- 75H71122P00865
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $6,416,080
Award facts
- Contract value 100% obligated
- $6,416,080.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73114, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services Indian Health Service (HHS IHS) awarded a $6.4 million firm fixed price purchase order to Amerisourcebergen Drug Corp Corporate Office Division to provide bebtelovimab for the period of September 8, 2022 through September 30, 2022. Bebtelovimab is a monoclonal antibody for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients. The place of performance for this sole-source contract is Oklahoma City, Oklahoma. No subcontractors were identified.
Quick answers
Who was awarded contract 75H71122P00865?
75H71122P00865 was awarded to Amerisourcebergen Drug Corp by Indian Health Service (Department of Health and Human Services) on September 8, 2022.
How much is contract 75H71122P00865 worth?
The government has obligated $6,416,080 on 75H71122P00865.
Was contract 75H71122P00865 competed?
The extent of competition for 75H71122P00865 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award